Clinical trial results show an experimental drug lowered tau levels in the brain and slowed some memory loss, but the data came with a surprise twist.
A new sort of Alzheimer’s drug shows glimmers of promise
Related Posts
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
- admin
- April 24, 2026
- 0
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
A ‘Golden Orb’ on the Ocean Floor Came From a Mysterious Animal
- admin
- May 23, 2026
- 0
A fascinating, unclassifiable orb found in the Gulf of Alaska is not an alien object, as some speculated, but the remains of a poorly documented animal.
What It Will Take to Make AI Sustainable
- admin
- May 13, 2026
- 0
Researcher Sasha Luccioni argues we need better emissions data and a better sense of how people are using AI in the first place.